Genky DrugStores Co., Ltd.
9267.T · JPX
9/30/2025 | 6/30/2025 | 3/31/2025 | 12/20/2024 | |
|---|---|---|---|---|
| Valuation | ||||
| PEG Ratio | -2.63 | 0.36 | -2.99 | 2.33 |
| FCF Yield | 0.00% | 0.00% | 0.00% | 0.00% |
| EV / EBITDA | 37.96 | 30.94 | 27.49 | 31.86 |
| Quality | ||||
| ROIC | 2.12% | 2.35% | 1.73% | 1.86% |
| Gross Margin | 20.25% | 20.81% | 20.29% | 20.13% |
| Cash Conversion Ratio | – | – | – | – |
| Growth | ||||
| Revenue 3-Year CAGR | 6.06% | 5.90% | 5.83% | 5.70% |
| Free Cash Flow Growth | 0.00% | 0.00% | 0.00% | 0.00% |
| Safety | ||||
| Net Debt / EBITDA | 5.13 | 6.05 | 5.68 | 6.83 |
| Interest Coverage | 47.05 | 44.03 | 51.00 | 68.35 |
| Efficiency | ||||
| Inventory Turnover | 1.69 | 1.56 | 1.50 | 1.45 |
| Cash Conversion Cycle | -4.38 | 13.21 | -1.09 | 8.95 |